Teva Pharmaceutical Industries Limited (NYSE:TEVA) management will conduct a conference call for 5th November 2020 at 8:00 AM Eastern Time to discuss financial results and companys performance for 3Q20.
The conference call will also be available live on the website www.tevapharm.com
Earnings Expectation
Teva Pharmaceutical Industries Limited is set to announce third quarter earning results on Thursday 5th November 2020, before market open.
Analysts surveyed by Thomson Reuters are predicting, TEVA to report 3Q20 income of $ 0.58 per share. For the full year, analysts anticipate top line of $ 16693.80 million, while looking forward to income of $ 2.51 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 16,600.00 million ~ $ 17,000.00 million, where as bottomline are predicted in a range of $ 2.30 ~ $ 2.55 per share
Click Here For More Historical Outlooks Of Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates through two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams.
